ACL vs CYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

53MEDIUM

CYC

CYCLOPHARM FPO [CYC]

41LOW

Score Breakdown

ACL CYC
Technical
62
41
Catalyst
88
51
Sentiment
50
50
Fundamental
67
69
Momentum
47
39
Risk Gate
36
50

Key Metrics

ACL Metric CYC
$423.4MMarket Cap$61.6M
520KAvg Volume (20d)345K
+7.3%Short InterestN/A
$2.97052-Week High$1.290
$1.83352-Week Low$0.450
+2.0%Daily Change-6.7%
$2.275Reference Price$0.490
+16.7%ROE-49.3%
+3.6%Profit Margin-53.3%

Active Signals

ACL Signals

Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Above-average volume (1.7x) on a green day — buyers stepping up
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)

CYC Signals

RSI drifting toward oversold territory — worth watching
Volume surging at 2.7x normal while price falls — heavy selling pressure
Watch out — volume is flowing out even as price holds up. Distribution pattern
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Low P/S ratio (1.9x)
Moderate revenue growth (+10%)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare ACL and CYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACL vs EBR →ACL vs ECS →ACL vs EIQ →ACL vs GSS →ACL vs HIQ →
ACL Full Analysis → CYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).